AngelaGowdyMysliwiecMD

Oncology • Fort Sam Houston, TX

Physician

Join to view full profile

Dr. Mysliwiec is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Mysliwiec's full profile

Already have an account?

Office
3551 Roger Brooke Drive
Brooke Army Medical Center
Fort Sam Houston, TX 78234
Is this information wrong?

Education & Training

San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1999 - 2002
Tripler Army Medical CenterResidency, Internal Medicine, 1996 - 1999
UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1996
United States Military AcademyBS, 1988 - 1992

Certifications & Licensure

NM State Medical License 2023 - 2026
FL State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
TX State Medical License 2019 - 2025
HI State Medical License 1998 - 2020
American Board of Internal Medicine Medical Oncology

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
Completed
Phase 2
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

126 citations
Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study.
James Wang, Brian O'Reilly, Ramesh Venkataraman, Vincent Mysliwiec, Angela G Mysliwiec> ;Sleep Medicine. 2009 Oct 1
12 citations
Thalidomide-induced organizing pneumonia.
Ashley A Feaver, David E McCune, Angela G Mysliwiec, Vincent Mysliwiec> ;Southern Medical Journal. 2006 Nov 1
18 citations
Anemia in men with advanced prostate cancer: incidence, etiology, and treatment.
Jeffrey G Nalesnik, Angela G Mysliwiec, Edith Canby-Hagino> ;Reviews in Urology. 2004 Jan 1
28 citations
Matrix metalloproteinases in colorectal cancer.
Angela G. Mysliwiec, Deborah L. Ornstein> ;Clinical Colorectal Cancer. 2002 Feb 1
Join now to see all

Press Mentions

NCCN Policy Summit Speakers Say Flexibility in Supporting and Accommodating Cancer Patients and Caregivers Helps Workplaces ThriveJune 17th, 2022